Protein Summary
Small GTPase required for proper nuclear import of RNA polymerase II (RNAPII) (PubMed:20855544, PubMed:21768307). May act at an RNAP assembly step prior to nuclear import (PubMed:21768307). Forms an interface between the RNA polymerase II enzyme and chaperone/scaffolding proteins, suggesting that it is required to connect RNA polymerase II to regulators of protein complex formation (PubMed:17643375). May be involved in nuclear localization of XPA (PubMed:11058119). This gene encodes a guanosine triphosphatase enzyme. The encoded protein may play a role in DNA repair and may function in activation of transcription. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2009]
- ENST00000264718
- ENSP00000264718
- ENSG00000198522
- ENST00000407583
- ENSP00000384255
- ENST00000424214
- ENSP00000398115
- ENST00000458167
- ENSP00000412170
- ENST00000503738
- ENSP00000427269
- ENST00000515877
- ENSP00000424678
- ENST00000610189
- ENSP00000476446
- ENST00000616939
- ENSP00000484680
- MBDIN
- RPAP4
- XAB1
- XAB1
- MBDIN
- NTPBP
- RPAP4
- ATPBD1A
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
co-expressed gene | 0.97 | ||
molecular function | 0.91 | ||
histone modification site profile | 0.84 | ||
transcription factor perturbation | 0.8 | ||
transcription factor binding site profile | 0.78 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 16.54 (req: < 5)
Gene RIFs: 8 (req: <= 3)
Antibodies: 178 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 16.54 (req: >= 5)
Gene RIFs: 8 (req: > 3)
Antibodies: 178 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 2
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0